Isolation and Phenotypic Characterization of Virulent Bacteriophages Against Multidrug-Resistant Escherichia coli and Its Phage-Resistant Variant from Sewage Sources

References

• Rajagopal K, Chandy SJ, Graham JP. A One Health Review of Community-Acquired Antimicrobial-Resistant Escherichia coli in India. Int J Environ Res Public Health. 2021;18(22):12089. doi:10.3390/ijerph182212089
   PubMed Web of Science ®Google Scholar
• Bitew A, Tsige E. High Prevalence of Multidrug-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: a Cross-Sectional Study at Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia. J Trop Med. 2020;2020:1–7. doi:10.1155/2020/6167234
   Web of Science ®Google Scholar
• Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2(2):123–140. doi:10.1038/nrmicro818
   PubMed Web of Science ®Google Scholar
• Ordaz-López VI, García-Herrera HM Cerda-Rivera. Urinary Tract Infection in Pregnancy: a Study of Pathogen and Bacterial Resistance in Mexico. J Fam Med. 2016;3(11):1–4.
   Google Scholar
• Ullah A, Qamash T, Khan FA, et al. Characterization of a coliphage as1 isolated from sewage effluent in Pakistan. Brazilian J Biol. 2022;82:1–7. doi:10.1590/1519-6984.240943
   Google Scholar
• Iredell J. Antimicrobial resistance. Microbiol Aust. 2019;40(2):55–56. doi:10.1071/MA19016
   Web of Science ®Google Scholar
• Farkas A, Tarco E, Butiuc-Keul A. Antibiotic resistance profiling of pathogenic Enterobacteriaceae from Cluj-Napoca, Romania. GERMS. 2019;9(1):17–27. doi:10.18683/germs.2019.1153
   PubMedGoogle Scholar
• Belete MA, Saravanan M. A systematic review on drug resistant urinary tract infection among pregnant women in developing countries in Africa and Asia; 2005-2016. Infect Drug Resist. 2020;13:1465–1477. doi:10.2147/IDR.S250654
   PubMed Web of Science ®Google Scholar
• Teklu DS, Negeri AA, Legese MH, Bedada TL, Woldemariam HK, Tullu KD. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019;8(1):39. doi:10.1186/s13756-019-0488-4
   PubMed Web of Science ®Google Scholar
• Zafer MM, El-Mahallawy HA, Abdulhak A, Amin MA, Al-Agamy MH, Radwan HH. Emergence of colistin resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli strains isolated from cancer patients. Ann Clin Microbiol Antimicrob. 2019;18(1):2021. doi:10.1186/s12941-019-0339-4
   Web of Science ®Google Scholar
• Knoll BM, Mylonakis E. Antibacterial bioagents based on principles of bacteriophage biology: an overview. Clin Infect Dis. 2014;58(4):528–534. doi:10.1093/cid/cit771
   PubMed Web of Science ®Google Scholar
• Vandamme EJ, Mortelmans K. A century of bacteriophage research and applications: impacts on biotechnology, health, ecology and the economy! J Chem Technol Biotechnol. 2019;94(2):323–342. doi:10.1002/jctb.5810
   Web of Science ®Google Scholar
• Zalewska-Piątek B, Piątek R. Phage therapy as a novel strategy in the treatment of urinary tract infections caused by E. coli. 2020;9:1–20.
   Google Scholar
• Parisien A, Allain B, Zhang J, Mandeville R, Lan CQ. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J Appl Microbiol. 2007;104(1):070802123828004. doi:10.1111/j.1365-2672.2007.03498.x
   Web of Science ®Google Scholar
• Moghadam MT, Amirmozafari N, Shariati A, et al. How phages overcome the challenges of drug resistant bacteria in clinical infections. Infect Drug Resist. 2020;13:45–61. doi:10.2147/IDR.S234353
   PubMed Web of Science ®Google Scholar
• Yu L, Wang S, Guo Z, et al. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli. Appl Microbiol Biotechnol. 2018;102(2):971–983. doi:10.1007/s00253-017-8591-z
   PubMed Web of Science ®Google Scholar
• Young ARJ, Narita M, Narita M. Cell senescence as both a dynamic and a static phenotype. Methods Mol Biol. 2013;965(1):1–13.
   PubMedGoogle Scholar
• Amankwah S, Adisu M, Gorems K, Abdella K, Kassa T. Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants. Infect Drug Resist. 2022. doi:10.2147/IDR.S367460
   PubMed Web of Science ®Google Scholar
• Kassa T. Bacteriophages Against Pathogenic Bacteria and Possibilities for Future Application in Africa. Infect Drug Resist. 2021;14:17–31. doi:10.2147/IDR.S284331
   PubMed Web of Science ®Google Scholar
• Batinovic W, Knowler R, Stanton R, et al. Bacteriophages in Natural and Artificial Environments. Pathogens. 2019;8(3):100. doi:10.3390/pathogens8030100
   PubMed Web of Science ®Google Scholar
• Romero-Calle D, Guimarães Benevides R, Góes-Neto A, Billington C. Bacteriophages as Alternatives to Antibiotics in Clinical Care. MDPI. 2019;8(3):138.
   Google Scholar
• Rahimzadeh G, Resch G, Rezai MS, Hevelaee EN. Characterization and lytic activity of isolated Escherichia coli bacteriophages against Escherichia coli in vitro. Iran J Med Sci. 2020;45(4):298–303. doi:10.30476/ijms.2019.45420
   PubMed Web of Science ®Google Scholar
• Alexyuk P, Bogoyavlenskiy A, Alexyuk M, Akanova K, Moldakhanov Y, Berezin V. Isolation and Characterization of Lytic Bacteriophages Active against Clinical Strains of E. coli and Development of a Phage Antimicrobial Cocktail. Viruses. 2022;14(11):2381. doi:10.3390/v14112381
   PubMed Web of Science ®Google Scholar
• Lukman C, Yonathan C, Magdalena S, Waturangi DE. Isolation and characterization of pathogenic Escherichia coli bacteriophages from chicken and beef offal. BMC Res Notes. 2020;13(1):8. doi:10.1186/s13104-019-4859-y
   PubMed Web of Science ®Google Scholar
• Hyman P. Phages for Phage Therapy: isolation, Characterization, and Host Range Breadth. MDPI. 2019;12(35):56.
   PubMedGoogle Scholar
• Chaudhary N, Narayan C, Mohan B, Taneja N. Characterization and in vitro activity of a lytic phage RDN37 isolated from community sewage water active against MDR Uropathogenic E. coli. Indian J Med Microbiol. 2021;39(3 343–348). doi:10.1016/j.ijmmb.2021.04.011
   PubMed Web of Science ®Google Scholar
• Jamal M, Hussain, T, Rajanna Das, C, Andleeb, S. Isolation and Characterization of a Myoviridae MJ1 Bacteriophage Against Multi-Drug Resistant Escherichia coli 3. Jundishapur J Microbiol. 2015;8(11):. doi:10.5812/jjm.25917
   PubMed Web of Science ®Google Scholar
• Oechslin F . Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy. Viruses. 2018;10(7):351. doi:10.3390/v10070351
   PubMed Web of Science ®Google Scholar
• Kim J, Park H, Ryu S, Jeon, B. Inhibition of Antimicrobial-Resistant Escherichia coli Using a Broad Host Range Phage Cocktail Targeting Various Bacterial Phylogenetic Groups. Front Microbiol. 2021;12(August):1–10. doi:10.3389/fmicb.2021.699630
   Google Scholar
• Friman VP . Resistance Evolution against Phage Combinations Depends on the Timing and Order of Exposure. MBio. 2019;10(5):1–15. doi:
   Web of Science ®Google Scholar
• Abedon ST, Danis-Wlodarczyk, KM, Wozniak, DJ. Phage Cocktail Development for Bacteriophage Therapy: toward Improving Spectrum of Activity Breadth and Depth. Pharmaceutical. 2021;14(10):1019 doi:10.3390/ph14101019.
   Google Scholar